Improving metabolic control during and after pancreatic surgery using continuous glucose monitoring (TIMECOG trial): a pilot randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29664

Enrollment

Registered

2019-09-30

Start date

2020-04-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic disease, diabetes mellitus

Interventions

Patients will receive a subcutaneous glucose sensor on the day before surgery. The glucose values measured will be used to guide treatment during the intraoperative and early postoperative period. Glu

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients, aged between 18 and 85, undergoing either pancreaticoduodenectomy or distal pancreatectomy, willing and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: Unable to communicate in Dutch or English, psychiatric disorder or any other condition the local investigator feels would interfere with trial participation or measurements

Design outcomes

Primary

Measure	Time frame
Percentage of time spent in glycaemic target range (i.e. glucose = 4 mmol/l and < 10 mmol/l).	—

Secondary

Measure	Time frame
Secondary outcomes include QoR-40,9 postoperative complications after 30 days and incidence of DM de novo.	—

Contacts

Public ContactRobert van Wilpe

Amsterdam UMC locatie AMC

r.vanwilpe@amsterdamumc.nl020 - 566 25 33

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)